

The MRI Patient Scanner market is experiencing robust growth, driven by increased demand for non-invasive diagnostic imaging. As of 2023, the market size is estimated to surpass $6 billion. Key drivers include technological advancements, aging populations, and rising prevalence of chronic diseases. Competitive landscapes are evolving with emerging players and innovative solutions.
◍ CEIA USA Ltd.
◍ ETS Lindgren
◍ Fujidenolo
◍ ITEL Telecomunicazioni
◍ Kopp Development
◍ Metrasens
◍ Biodex
The MRI patient scanner market features companies like CEIA USA Ltd., ETS Lindgren, and Fujidenolo, which enhance scanner technology to improve diagnostic precision. Metrasens and Biodex focus on safety and functionality, driving market growth. Sales revenue figures include:
- CEIA USA Ltd.: $45 million
- Fujidenolo: $30 million
- Metrasens: $25 million.
Request Sample Report
◍ Hospitals
◍ Other Healthcare Institutions
◍ Wall-mounted MRI Patient Scanner
◍ Handheld MRI Patient Scanner
◍ Mobile MRI Patient Scanner
Request Sample Report
Request Sample Report
$ X Billion USD